SZSE Releases
Companies
Releases
Pricing
Home
/
Companies
/
Hybio Pharmaceutical Co., Ltd.
/
Release
300199
SZSE
Announcement on the III Phase Clinical Trial Data Obtained for Semaglutide Injection
Hybio Pharmaceutical Co., Ltd.
·
May 6, 2026
Full Translation